| Apelin12 in Acne Vulgaris (NCT03480503) | Assiut University | 2018-05-01 |
| Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris (NCT03522441) | Akorn, Inc. | 2018-04-27 |
| The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne (NCT05216289) | Federal University of São Paulo | 2018-04-01 |
| Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients (NCT03883269) | Centre for Human Drug Research, Netherlands | 2018-03-20 |
| Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. (NCT03334682) | Nantes University Hospital | 2018-01-31 |
| A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne (NCT03450369) | Naked Biome, Inc. | 2018-01-24 |
| Acne Remission Maintenance by Weekend Systemic Isotretinoin (NCT06451237) | Alexandria University | 2018-01-20 |
| Acne Vulgaris Related Microbiology and Serology (NCT04056598) | Sanofi | 2018-01-18 |
| Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery (NCT03573115) | Merete Haedersdal | 2018-01-04 |
| Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris. (NCT03186222) | Assiut University | 2018-01-01 |
| Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face (NCT03393494) | Padagis LLC | 2017-12-13 |
| Relationship of Whole Blood Zinc Levels to Acne Severity (NCT04975412) | East Avenue Medical Center, Philippines | 2017-11-27 |
| Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars (NCT04870489) | Tel-Aviv Sourasky Medical Center | 2017-11-01 |
| A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris (NCT03170388) | Bausch Health Americas, Inc. | 2017-10-05 |
| A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris (NCT03307577) | Therapeutics, Inc. | 2017-10-05 |
| A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris (NCT03599193) | Dr. Reddy's Laboratories Limited | 2017-10-04 |
| Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris (NCT03303170) | Sebacia, Inc. | 2017-09-25 |
| Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgaris (NCT03264287) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2017-09-01 |
| A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris (NCT03341910) | Dr. Reddy's Laboratories Limited | 2017-08-21 |
| To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris (NCT03427554) | Sun Pharmaceutical Industries, Inc. | 2017-08-21 |
| To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris (NCT03433378) | Sun Pharmaceutical Industries, Inc. | 2017-08-04 |
| A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris (NCT03290027) | Dr. Reddy's Laboratories Limited | 2017-07-31 |
| The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color (NCT03402893) | Derm Research, PLLC | 2017-07-28 |
| A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris (NCT03271021) | Vyne Therapeutics Inc. | 2017-07-17 |
| A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302) (NCT03168334) | Bausch Health Americas, Inc. | 2017-07-11 |
| A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks (NCT03292640) | Dr. Reddy's Laboratories Limited | 2017-07-06 |
| Correlation Between Dehydroepiandrosterone Sulfate and Sebum Level in Adult Female Acne Vulgaris (NCT04555018) | Dr.dr.Irma Bernadette, SpKK (K) | 2017-06-01 |
| Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars (NCT03933033) | Aswan University Hospital | 2017-06-01 |
| A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris (NCT03128723) | Johnson & Johnson Consumer Inc. (J&JCI) | 2017-04-30 |
| A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne (NCT03124381) | Johnson & Johnson Consumer Inc. (J&JCI) | 2017-04-08 |
| Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females. (NCT03106766) | Next Science TM | 2017-03-27 |
| A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris (NCT03127956) | Dermira, Inc. | 2017-03-21 |
| Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel (NCT02946788) | BioPharmX, Inc. | 2017-03-13 |
| A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris (NCT03073486) | Dermira, Inc. | 2017-02-06 |
| Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne (NCT02932267) | Galderma R&D | 2017-02-02 |
| A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris (NCT03028363) | Dermira, Inc. | 2016-12-27 |
| Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne (NCT02998671) | Novartis Pharmaceuticals | 2016-12-22 |
| Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography (NCT03524040) | Merete Haedersdal | 2016-12-01 |
| Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris (NCT02959970) | Almirall, S.A. | 2016-10-31 |
| An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris (NCT02720627) | Cassiopea SpA | 2016-10-28 |
| Efficacy Study in Patients With Acne Vulgaris. (NCT02935036) | Sun Pharmaceutical Industries, Inc. | 2016-10-03 |
| A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT02886715) | Fougera Pharmaceuticals Inc. | 2016-09-21 |
| Venus Versa Diamondpolar Applicator Treatment Followed by AC Dual Applicator Treatment for Facial Acne Vulgaris (NCT02924428) | Venus Concept | 2016-09-01 |
| Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT03132194) | Sun Pharmaceutical Industries, Inc. | 2016-08-08 |
| Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA (NCT03039634) | Sienna Labs | 2016-08-01 |
| BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris (NCT02815332) | BioPharmX, Inc. | 2016-08-01 |
| Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris (NCT02832063) | AOBiome LLC | 2016-08-01 |
| Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia (NCT03626298) | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | 2016-08-01 |
| Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris (NCT02801903) | Novan, Inc. | 2016-06-07 |
| TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris (NCT02796066) | Thesan Pharmaceuticals, Inc. | 2016-06-01 |
| Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring (NCT03522922) | Sohag University | 2016-06-01 |
| Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars (NCT02735421) | Galderma R&D | 2016-05-13 |
| P3 Long Term Safety Study of Once Daily SB204 in Acne (NCT02798120) | Novan, Inc. | 2016-05-12 |
| A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne (NCT02815267) | Vyne Therapeutics Inc. | 2016-05-01 |
| Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris (NCT02905851) | University of California, Davis | 2016-05-01 |
| A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne (NCT02815280) | Vyne Therapeutics Inc. | 2016-05-01 |
| Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris (NCT02661958) | Sol-Gel Technologies, Ltd. | 2016-05-01 |
| Studying the Skin Microbiome and the Potential of a Topical Probiotic Cream for Patients With Acne (NCT03469076) | University Hospital, Antwerp | 2016-04-25 |
| BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes (NCT02709096) | BioPharmX, Inc. | 2016-04-01 |
| Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne (NCT03071549) | Cairo University | 2016-04-01 |
| Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris (NCT02721173) | All India Institute of Medical Sciences, Bhubaneswar | 2016-04-01 |
| A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. (NCT02698436) | Johnson & Johnson Consumer and Personal Products Worldwide | 2016-03-31 |
| An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris (NCT02682264) | Cassiopea SpA | 2016-03-09 |
| A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris (NCT02647528) | Sadick Research Group | 2016-03-01 |
| Lipidome and Microbiome Profile of Acne (NCT02713607) | University of California, Davis | 2016-03-01 |
| Timolol for the Treatment of Acne and Rosacea (NCT02774590) | Johns Hopkins University | 2016-03-01 |
| P3 Study in Acne Comparing Once Daily SB204 and Vehicle (NCT02672332) | Novan, Inc. | 2016-02-22 |
| P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne (NCT02667444) | Novan, Inc. | 2016-02-19 |
| Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris (NCT02865005) | Seegpharm S.A. | 2016-02-01 |
| Low Glycemic Index and Load Diet for the Treatment of Acne (NCT03585140) | Centro Dermatológico Dr. Ladislao de la Pascua | 2016-01-01 |
| Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris (NCT02566369) | Galderma R&D | 2015-11-30 |
| A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) (NCT02608476) | Cassiopea SpA | 2015-11-16 |
| Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris (NCT02556788) | Galderma R&D | 2015-11-01 |
| Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (NCT03003247) | Bausch Health Americas, Inc. | 2015-11-01 |
| DUAC® Early Onset Efficacy Study in Japanese Subjects (NCT02557399) | GlaxoSmithKline | 2015-10-07 |
| A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris (NCT02604680) | Braintree Laboratories | 2015-10-01 |
| A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 (NCT02581072) | Novan, Inc. | 2015-10-01 |
| De Novo Lipogenesis of Sebaceous Glands in Acne (NCT02620813) | University of California, Davis | 2015-10-01 |
| A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris (NCT02571998) | Maruho Co., Ltd. | 2015-10-01 |
| A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (NCT02537483) | Valeant Pharmaceuticals | 2015-10-01 |
| A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel (NCT02656043) | Xenon Pharmaceuticals Inc. | 2015-09-17 |
| Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris (NCT02525822) | Valeant Pharmaceuticals | 2015-09-01 |
| A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris (NCT02535871) | Valeant Pharmaceuticals | 2015-09-01 |
| Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris (NCT02709902) | Sun Pharmaceutical Industries, Inc. | 2015-09-01 |
| A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris (NCT02491060) | Valeant Pharmaceuticals | 2015-09-01 |
| A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris (NCT02656485) | AOBiome LLC | 2015-08-05 |
| Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris (NCT02589405) | Galderma R&D | 2015-08-01 |
| Risk Minimisation Study for Diane-35 and Its Generics (NCT02410031) | Bayer | 2015-06-26 |
| Cultural Differences in Treatment Preferences and Perceptions of Acne (NCT03192163) | Northwestern University | 2015-06-01 |
| Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris (NCT02616614) | Actavis Inc. | 2015-05-01 |
| Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases (NCT02349399) | Bayer | 2015-05-01 |
| A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris (NCT02395549) | Mimetica Pty Limited | 2015-04-01 |
| To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. (NCT02465632) | Glenmark Pharmaceuticals Ltd. India | 2015-04-01 |
| A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris (NCT02431052) | Dermira, Inc. | 2015-04-01 |
| CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris (NCT02385760) | Celtaxsys, Inc. | 2015-04-01 |
| A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris (NCT02413346) | Almirall, S.A. | 2015-03-20 |
| A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne (NCT02404285) | Next Science TM | 2015-03-01 |
| CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris (NCT02189629) | Galderma R&D | 2015-02-23 |
| Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products (NCT02731105) | GWT-TUD GmbH | 2015-02-01 |
| A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris (NCT02595034) | Sun Pharmaceutical Industries, Inc. | 2015-01-01 |